19-49636664-G-A
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_006270.5(RRAS):c.408C>T(p.Pro136Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00068 in 1,614,118 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P136P) has been classified as Likely benign.
Frequency
Consequence
NM_006270.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- Noonan syndrome and Noonan-related syndromeInheritance: AD Classification: STRONG Submitted by: G2P
- Noonan syndromeInheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| RRAS | NM_006270.5 | c.408C>T | p.Pro136Pro | synonymous_variant | Exon 4 of 6 | ENST00000246792.4 | NP_006261.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.00347  AC: 528AN: 152174Hom.:  2  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.000911  AC: 229AN: 251240 AF XY:  0.000633   show subpopulations 
GnomAD4 exome  AF:  0.000389  AC: 569AN: 1461826Hom.:  3  Cov.: 32 AF XY:  0.000323  AC XY: 235AN XY: 727216 show subpopulations 
Age Distribution
GnomAD4 genome  0.00347  AC: 528AN: 152292Hom.:  2  Cov.: 31 AF XY:  0.00338  AC XY: 252AN XY: 74470 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Benign:3 
- -
Variant summary: The RRAS c.408C>T (p.Pro136Pro) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect ESE site of SF2/ASF and SC35. These predictions have yet to be confirmed by functional studies. This variant was found in 132/121062 control chromosomes from ExAC, predominantly observed in the African subpopulation at a frequency of 0.010667 (110/10312). This frequency is about 4267 times the estimated maximal expected allele frequency of a pathogenic RRAS variant (0.0000025), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications. Taken together, this variant is classified as Benign. -
- -
not specified    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Noonan syndrome    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at